My Retina Tracker® Panel
A comprehensive 110-gene panel designed to identify pathogenic variants associated with inherited retinal degenerations and related retinal dystrophies.
Accessed through the My Retina Tracker® Sponsored Testing Program•Sponsored by Foundation Fighting Blindness•Performed by Prevention Genetics
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
The My Retina Tracker Program provides sponsored 110-gene panel testing via NGS for patients with a clinically confirmed inherited retinal disease. The program supports molecular diagnosis to inform management, identify candidacy for gene-targeted therapies, and facilitate enrollment in clinical research. Testing and genetic counseling are provided at no cost to the patient, and ordering carries no prescribing or purchase obligation.
When to consider this test
Patient selection
- Residency: Patient resides in the U.S. or a U.S. territory.
- Clinical criteria: Patient has a clinically confirmed IRD eligible for the program.
- Family status: Patient has no first-degree relatives previously tested through the Program.
- Prior testing: Patient has not undergone an IRD panel of 32+ genes, WES, or WGS within the last 5 years.
- Prior results: Patient has not received an IRD-related molecular diagnosis from any previous testing.
- Registry requirement: Patient agrees to enroll in the My Retina Tracker Registry and allow results to be shared.
- Familial variant testing: Relatives of individuals with a positive or indeterminate Program result may qualify for no-cost targeted variant testing.
Workflow
How to use this program
- 1
Apply for Participation
Submit the provider application to the Foundation Fighting Blindness. Approval is required before you can order testing through the Program.
- 2
Create a Program Account
Set up your Program-specific account here. Ordering access will be granted after the Foundation processes your request.
- 3
Share Program Materials
Use the Program webform link provided by the Foundation to submit patient details. Patients receive study materials and consent forms via email.
- 4
Download Patient’s HIPAA Form
Once the patient signs electronically, you will receive the executed HIPAA release by email. Download and save it for the test requisition form.
- 5
Complete the TRF
Access the Program portal to enter clinical information, upload the HIPAA release, and select your genetic counseling preference—this choice cannot be changed later.
- 6
Determine Sample Collection
Collect the sample in clinic or request a kit be mailed to the patient. Label specimens with at least two identifiers. Deliveries are accepted Monday–Saturday.
- 7
Review Results and Counsel
Results are typically returned in about 21 days. Discuss results with the patient or coordinate post-test counseling through InformedDNA, based on your selection.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Prevention Genetics, a CLIA-certified laboratory (CLIA 52D2065132) and College of American Pathologists (CAP) certified laboratory (CAP 7185561). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients with inherited retinal disease are appropriate for the My Retina Tracker Program's sponsored genetic testing?
The My Retina Tracker Program is designed for patients with a clinically confirmed diagnosis of an inherited retinal disease who meet the program's specific eligibility criteria. Patients must be enrolled through the program workflow and complete all required consent and HIPAA documentation. Full eligibility details are available through the program's ordering portal.
What does the My Retina Tracker 110-gene panel cover, and what methodology is used?
The My Retina Tracker Panel covers 110 genes associated with inherited retinal diseases and is performed using next-generation sequencing (NGS). Testing is carried out by Prevention Genetics, a CAP-accredited and CLIA-certified laboratory. The panel is designed to support molecular diagnosis across a broad spectrum of IRD phenotypes.
What specimen types are accepted for the My Retina Tracker inherited retinal disease panel, and what is the turnaround time?
Prevention Genetics accepts whole blood, saliva, or OCD-100 buccal swab specimens for the My Retina Tracker Panel. Turnaround time is 2 to 3 weeks from specimen receipt. Specimen collection and shipping details are available through the Prevention Genetics ordering platform.
Is genetic counseling included with the My Retina Tracker Program for inherited retinal disease testing?
Yes, the My Retina Tracker Program includes genetic counseling support as part of the sponsored testing program at no cost to the patient or ordering provider. Counseling services are available to assist with pre-test education and post-test results interpretation.
Does ordering the My Retina Tracker sponsored IRD panel create any purchase or prescribing obligation for the clinician?
No. Ordering through the My Retina Tracker Program carries no purchase or prescribing obligation for the clinician. The program is fully sponsored, meaning testing and counseling are provided at no cost to the patient. The program is available for eligible patients residing in the United States or U.S. territories.
Can familial variant testing be ordered through the My Retina Tracker Program for relatives of patients with inherited retinal disease?
The My Retina Tracker Program may offer no-cost familial variant testing for biological relatives of patients who received a positive or, in some cases, an indeterminate result through the program. Specific eligibility requirements apply, and details can be confirmed through the program's ordering workflow.
Which patients are eligible for My Retina Tracker Inherited Retinal Disease genetic testing?
Patients may qualify for My Retina Tracker if they meet the program's eligibility criteria:
- Residency: Patient resides in the U.S. or a U.S. territory.
- Clinical criteria: Patient has a clinically confirmed IRD eligible for the program.
- Family status: Patient has no first-degree relatives previously tested through the Program.
- Prior testing: Patient has not undergone an IRD panel of 32+ genes, WES, or WGS within the last 5 years.
- Prior results: Patient has not received an IRD-related molecular diagnosis from any previous testing.
- Registry requirement: Patient agrees to enroll in the My Retina Tracker Registry and allow results to be shared.
- Familial variant testing: Relatives of individuals with a positive or indeterminate Program result may qualify for no-cost targeted variant testing.
See an issue with this program?